Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Racephedrine

From Wikipedia, the free encyclopedia
Pharmaceutical drug
Pharmaceutical compound
Racephedrine
(−)-(1R,2S)-ephedrine (top),
(+)-(1S,2R)-ephedrine (bottom)
Clinical data
Trade namesEfetonina; Ephoxamine
Other namesRacemic ephedrine; (±)-Ephedrine;dl-Ephedrine; (1RS,2SR)-Ephedrine
Drug classNorepinephrine releasing agent;Sympathomimetic;Bronchodilator;Psychostimulant
Identifiers
  • 2-(methylamino)-1-phenylpropan-1-ol
CAS Number
PubChemCID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC10H15NO
Molar mass165.236 g·mol−1
3D model (JSmol)
  • CC(C(C1=CC=CC=C1)O)NC
  • InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3
  • Key:KWGRBVOPPLSCSI-UHFFFAOYSA-N

Racephedrine, also known asracemic ephedrine and sold under the brand namesEfetonina andEphoxamine among others, is theracemic form ofephedrine which has been used as abronchodilator to treatasthma.[1][2][3][4][5] More specifically, it is a racemic mixture of (1R,2S)- and (1S,2R)-enantiomers.[3] Conversely, ephedrine is theenantiopure (1R,2S)-enantiomer.[1] Racephedrine has been marketed for medical use inItaly.[1] Like ephedrine, racephedrine is areleasing agent ofnorepinephrine and to a much lesser extent ofdopamine.[6][7][8][9] Both ephedrine enantiomers are active in this regard, but ephedrine ((1R,2S)-ephedrine) has greaterpotency than (1S,2R)-ephedrine.[6][7][8][9]

Monoamine release by ephedrine and related agents (EC50Tooltip half maximal effective concentration, nM)[6][7]
CompoundNETooltip NorepinephrineDATooltip Dopamine5-HTTooltip SerotoninRef
Dextroamphetamine (S(+)-amphetamine)6.6–7.25.8–24.8698–1765[8][10]
S(–)-Cathinone12.418.52366[9]
Ephedrine ((–)-ephedrine; (1R,2S)-ephedrine)43.1–72.4236–1350>10000[8]
(+)-Ephedrine ((1S,2R)-ephedrine)2182104>10000[8][9]
Dextromethamphetamine (S(+)-methamphetamine)12.3–13.88.5–24.5736–1291.7[8][11]
Levomethamphetamine (R(–)-methamphetamine)28.54164640[8]
(+)-Phenylpropanolamine ((+)-norephedrine)42.1302>10000[9]
(–)-Phenylpropanolamine ((–)-norephedrine)1371371>10000[9]
Cathine ((+)-norpseudoephedrine)15.068.3>10000[9]
(–)-Norpseudoephedrine30.1294>10000[9]
(–)-Pseudoephedrine40929125>10000[9]
Pseudoephedrine ((+)-pseudoephedrine)2241988>10000[9]
The smaller the value, the more strongly the substance releases the neurotransmitter. See alsoMonoamine releasing agent § Activity profiles for a larger table with more compounds.

Racephedrine has been used in a variety ofcombination drugs with other agents, includingtheophylline,aminophylline,oxtriphylline,phenobarbital,pentobarbital,pyrilamine,phenacetin,salicylamide,ascorbic acid, andopium, among others.[12] Brand names of these combination preparations have included Amiphedrin, Amodrine, Amodrine E C, Asphamal-D, Asthmadrin, Cenamal, Cholarace, Phedrahist, Respirol, Salidin, Synate-M, and Synophedal.[12]

See also

[edit]

References

[edit]
  1. ^abcSchweizerischer Apotheker-Verein (2000).Index Nominum 2000: International Drug Directory. Medpharm Scientific Publishers. p. 390.ISBN 978-3-88763-075-1. Retrieved30 August 2024.
  2. ^"Racephedrine: Uses, Interactions, Mechanism of Action".DrugBank Online. 31 December 1995. Retrieved30 August 2024.
  3. ^ab"Racephedrine".PubChem. Retrieved30 August 2024.
  4. ^Tapay NJ (July 1961). "A racephedrine-phenyltoloxamine-containing compound (Ephoxamine) in the treatment of bronchial asthma".Curr Ther Res Clin Exp.3:305–312.PMID 13775237.
  5. ^Dubois de Montreynaud JM, Kochman S, Charreire J, Fondeville D, Houlon JP, Doco (1968). "[Delayed-action effect of a racephedrine, theophylline and phenobarbital combination on asthma. Study on 100 cases]".Therapie (in French).23 (4):987–994.PMID 5744603.
  6. ^abcRothman RB, Baumann MH (2003). "Monoamine transporters and psychostimulant drugs".Eur. J. Pharmacol.479 (1–3):23–40.doi:10.1016/j.ejphar.2003.08.054.PMID 14612135.
  7. ^abcRothman RB, Baumann MH (2006). "Therapeutic potential of monoamine transporter substrates".Curr Top Med Chem.6 (17):1845–1859.doi:10.2174/156802606778249766.PMID 17017961.
  8. ^abcdefgRothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (January 2001). "Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin".Synapse.39 (1):32–41.doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3.PMID 11071707.
  9. ^abcdefghijRothman RB, Vu N, Partilla JS, Roth BL, Hufeisen SJ, Compton-Toth BA, Birkes J, Young R, Glennon RA (October 2003). "In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates".J Pharmacol Exp Ther.307 (1):138–145.doi:10.1124/jpet.103.053975.PMID 12954796.
  10. ^Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW (2013)."Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products".Neuropsychopharmacology.38 (4):552–562.doi:10.1038/npp.2012.204.PMC 3572453.PMID 23072836.
  11. ^Baumann MH, Ayestas MA, Partilla JS, Sink JR, Shulgin AT, Daley PF, Brandt SD, Rothman RB, Ruoho AE, Cozzi NV (April 2012)."The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue".Neuropsychopharmacology.37 (5):1192–203.doi:10.1038/npp.2011.304.PMC 3306880.PMID 22169943.
  12. ^abProject Label: Alphabetical Listing by Drug Product. Department of Justice, Drug Enforcement Administration, Office of Compliance and Regulatory Affairs, Regulatory Support Division, Information Systems Section. 1979. p. 235. Retrieved2024-08-31.


Adrenergics,inhalants
Short-acting β2 agonists
Long-acting β2 agonists
Ultra-long-acting β2 agonists
Other
Glucocorticoids
Anticholinergics/
muscarinic antagonist
Mast cell stabilizers
Xanthines
Eicosanoid inhibition
Leukotriene antagonists
Arachidonate 5-lipoxygenase inhibitors
Thromboxane receptor antagonists
Non-xanthinePDE4 inhibitors
Others/unknown
Combination products
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Phenethylpyrrolidines
Racetams
Psychedelics
Tropanes
Tryptamines
Others
DRAsTooltip Dopamine releasing agents
NRAsTooltip Norepinephrine releasing agents
SRAsTooltip Serotonin releasing agents
Others
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=Racephedrine&oldid=1328679129"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp